USPTO serial 79135148
MIDATECH
Reviewed by CopyMark Law Group
Reg. 4680241Status 404
- Filing date
- Status date
- Registration date
- Feb 3, 2015
- Examiner
- VAGHANI, MAYUR C
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MIDATECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Manuel R. Valcarcel
Manuel R. Valcarcel Greenberg Traurig, P.A.333 S.E. 2nd Avenue, 44th FloorMiami, FL 33131UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Active chemical ingredients for use in the manufacture of pharmaceuticals and medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; Active chemical ingredients for use in the manufacture of cosmetics, namely, nanoparticles for use as carriers for cosmetic preparations; nano-particle ingredients for use in pharmaceuticals, medicines and cosmetics, namely, active chemical ingredients in the nature of nanoparticles for use in the manufacture of pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceuticals and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles ] | SECTION 71 - CANCELLED | — |
| 009 | [ Computer software for the sampling, collection, analysis and testing of nano-particles; computer software for the diagnosis of medical conditions; electronic devices, namely, computers, laboratory analyzers in the nature of residual gas analyzers, liquid analyzers, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence or quantity of target chemicals, biologics, contaminants and nano-particles, untrasound probes for testing nano-particles for non-medical purposes, scientific diagnostic apparatus in the nature of diagnostic apparatus for testing food, diagnostic apparatus for the detection of pathogens for laboratory or research use, spectroscopic devices in the nature of laboratory spectroscopes, microfluidic devices in the nature of electronic analyzers for the transport and analysis for fluid samples by using microfluidic and nanofluidic channels formed on or in a substrate, laboratory equipment in the nature of digital microfluidic instruments for nucleic acid sample preparation, laboratory equipment in the nature of digital microfluidic instruments for genomic analysis, equipment for microfluidic analysis, research laboaratory analyzers for measuring, testing and analyzing fluids, laboratory microarray devices for the sampling, collection, analysis and testing of nano-particles ] | SECTION 71 - CANCELLED | — |
| 010 | [ Medical devices, namely, medical diagnostic kits consisting primarily of probes, buffers and reagents for use in nano-particle testing, medical sample preparation devices for medical diagnostic uses, spectroscopic devices in the nature of microscopes for surgical operations, endoscopic equipment, otoscopes, microfluidic devices in the nature of medical fluid injectors, medical devices for obtaining body fluid samples containing nano-particles and medical diagnostic instuments for analysis of body fluids, microarray devices in the nature of microarrays for surgical use, microarrays for medical diagnostic use, and microarrays for the sampling, collection, analysis and testing of nano-particles for medical purposes; probes for medical purposes ] | SECTION 71 - CANCELLED | — |
| 040 | [ Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices ] | SECTION 71 - CANCELLED | — |
| 042 | [ Scientific research services in the field of nano-particle technology; ] pharmaceutical development and drug development and discovery services; testing, efficiency, quality evaluation and technical advisory services in the field of design, development and scientific research of [ nano-particles, ] pharmaceuticals [ and nano-medicine; nano-particle testing, quality evaluation and scientific research laboratory services ] | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Midatech Limited
- Other trademarks owned by Midatech Limited
- Other trademarks owned by Midatech Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named MIDATECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 30, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Oct 30, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 3, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 2, 2022 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 1, 2022 | INPC | INVALIDATION PROCESSED | — |
| Nov 5, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 5, 2022 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 5, 2022 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Feb 16, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 26, 2021 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 18, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 3, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 10, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 20, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 3, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 3, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 3, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 3, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 18, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 18, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 14, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 29, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 29, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 29, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 16, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 14, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 14, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 14, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 14, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 14, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 24, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2014 | ALIE | ASSIGNED TO LIE | — |
| Mar 5, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 30, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 10, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 10, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 10, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 10, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 6, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 5, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |